- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07302152
Evaluation of Elastosonographic Techniques Implemented on Ultrasound Systems for the Assessment of Liver Stiffness
December 10, 2025 updated by: Gianluigi Poma, Fondazione IRCCS Policlinico San Matteo di Pavia
The assessment of liver stiffness is essential in patients with suspected or confirmed chronic liver disease, as clinical management depends on the degree and progression of hepatic fibrosis, which increases liver hardness.
In recent years, non-invasive elastosonographic techniques have been introduced to estimate liver fibrosis.
The first to be implemented was Transient Elastography (TE), which has shown high accuracy in identifying significant fibrosis and cirrhosis, particularly in patients with HCV-related chronic liver disease, and has been endorsed by The European Association for the Study of the Liver (EASL) guidelines as an alternative to liver biopsy.
More recently, shear-wave elastography techniques integrated into conventional ultrasound systems have been developed, offering the advantage of real-time B-mode ultrasound guidance.
The aim of this study is to compare these techniques with each other and with TE.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
72
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pavia
-
Pavia, Pavia, Italy, 27100
- Fondazione IRCCS Policlinico San Matteo, SSD Malattie Infettive 3 - Ecografia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age > 18 years, ability to hold breath during image acquisition, informed consent.
Exclusion Criteria:
- any condition that, in the investigator's clinical judgment, would make further participation in the study unacceptable for that individual patient.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Age > 18 years cohort
|
Measurement performed in the right intercostal space, using the median value of 5 measurements for 2D shear wave and 10 measurements for point shear wave
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
elastosonographic
Time Frame: up to 24 months
|
Measurement taken in the right intercostal space, median value of 5 measurements for 2D shear wave and 10 measurements for point shear wave.
|
up to 24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 16, 2023
Primary Completion (Actual)
May 5, 2025
Study Completion (Actual)
May 5, 2025
Study Registration Dates
First Submitted
November 26, 2025
First Submitted That Met QC Criteria
December 10, 2025
First Posted (Actual)
December 24, 2025
Study Record Updates
Last Update Posted (Actual)
December 24, 2025
Last Update Submitted That Met QC Criteria
December 10, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- p_12
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Stiffness
-
Medical University of GrazCompleted
-
Selcuk UniversityCompletedLiver Stiffness | Spleen Stiffness | Shear Wave Elastography in Healthy Children | Normal Organ Elasticity | Pediatric ElastographyTurkey (Türkiye)
-
Mehmet Akif AĞIRRecruitingMalnutrition in Children | Liver Stiffness | Shear Wave Elastography | Spleen StiffnessTurkey
-
Shengjing HospitalRecruiting
-
China Medical University HospitalUnknownLiver Fibrosis | Visceral StiffnessTaiwan
-
Universitair Ziekenhuis BrusselNot yet recruitingPrimary Biliary Cholangitis | Spleen StiffnessBelgium
-
Calliditas Therapeutics Suisse SACompletedPrimary Biliary Cholangitis | Liver StiffnessUnited States, Spain, France, Australia, Israel, Canada, Switzerland, Italy, New Zealand, Germany, Poland, Greece, United Kingdom, Belgium, Austria, Czechia, Hungary, Sweden
-
Chinese University of Hong KongNot yet recruitingArterial Stiffness
-
University of PrimorskaCompleted
-
Superior UniversityActive, not recruitingStiffness; SacroiliacPakistan